Add-on fenfluramine in Lennox Gastaut epilepsy

Trial Profile

Add-on fenfluramine in Lennox Gastaut epilepsy

Recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Dec 2016

At a glance

  • Drugs Fenfluramine (Primary)
  • Indications Lennox-Gastaut syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Dec 2016 According to a Zogenix media release, interim analysis data from this study were presented at the 70th Annual American Epilepsy Society (AES) meeting.
    • 05 Dec 2016 Results (n=13) published in the Zogenix Media Release.
    • 23 Nov 2016 According to a Zogenix media release, interim data (8 weeks) will be presented at 70th Annual American Epilepsy Society Meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top